Neil is responsible for search and evaluation of pharmaceutical products and platforms as well as the support of various strategic initiatives on the West Coast.  Prior to joining GSK, he was head of business development at Cadence Pharmaceuticals (acquired by Mallinckrodt) and helped found two biotech companies, including Mpex Pharmaceuticals (acquired by Aptalis).